Fig. 6.
There was no difference in the survival between the patients assigned to receive G-CSF (median, 2.4 years) and those assigned to placebo (median, 1.8 years) (P = .25).
There was no difference in the survival between the patients assigned to receive G-CSF (median, 2.4 years) and those assigned to placebo (median, 1.8 years) (P = .25).
